Ionis Pharmaceuticals
IONS
IONS
373 hedge funds and large institutions have $7.09B invested in Ionis Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 122 increasing their positions, 131 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
373
Holders Change
+13
Holders Change %
+3.61%
% of All Funds
7.67%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
50
Increased
122
Reduced
131
Closed
34
Calls
$42.7M
Puts
$48.7M
Net Calls
-$5.98M
Net Calls Change
+$9.66M
Top Buyers
1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$286M |
2 |
BlackRock
New York
|
+$28.5M |
3 |
First Trust Advisors
Wheaton,
Illinois
|
+$21.4M |
4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$19.9M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
Top Sellers
1 |
Wellington Management Group
Boston,
Massachusetts
|
-$133M |
2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$31.1M |
3 |
BI
BVF Inc
San Francisco,
California
|
-$30.8M |
4 |
Citadel Advisors
Miami,
Florida
|
-$28.1M |
5 |
ClearBridge Investments
New York
|
-$21.9M |